Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Financial Flexibility Index
Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Financial Flexibility Index of -2734.54x as of September 2025. Free cash flow of $-2.36 Billion (operating CF $-2.36 Billion minus capex $0.00) represents -2735% of total liabilities ($862.22K). Check Lipella Pharmaceuticals Inc. Common Stoc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lipella Pharmaceuticals Inc. Common Stock Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Lipella Pharmaceuticals Inc. Common Stock across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Lipella Pharmaceuticals Inc. Common Stoc generate cash.
Annual Financial Flexibility Index for Lipella Pharmaceuticals Inc. Common Stock (2019–2024)
Year-by-year free cash flow to debt coverage for Lipella Pharmaceuticals Inc. Common Stock. Explore Lipella Pharmaceuticals Inc. Common Stoc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.24x | $-3.95 Million | $-3.95 Million | $754.42K | ▲ +27.7% |
| 2023 | -7.25x | $-3.14 Million | $-3.15 Million | $432.73K | ▼ -404.4% |
| 2022 | -1.44x | $-1.83 Million | $-1.83 Million | $1.27 Million | ▲ +14.4% |
| 2021 | -1.68x | $-989.27K | $-989.27K | $589.34K | ▼ -2788.3% |
| 2020 | -0.06x | $-28.58K | $-28.58K | $491.70K | ▲ +64.7% |
| 2019 | -0.16x | $-39.12K | $-39.12K | $237.26K | — |